ArticleFrontiers in nutrition2025
Association of inflammation geriatric nutritional risk index with all-cause and CVD mortality in patients with osteoarthritis.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Osteoarthritis (OA) is a prevalent chronic disease affecting the elderly, with significant implications for morbidity and mortality. The geriatric nutritional risk index (GNRI) score is a tool for assessing the nutritional status of elderly patients and has been linked to mortality outcomes in various chronic diseases. However, its relationship with mortality in OA patients remains underexplored. Objective: To evaluate the association between GNRI levels and all-cause and cardiovascular mortality in patients with OA, using data from NHANES (1999-2018). Methods: This cohort study included 3,023 OA patients. GNRI was calculated using serum albumin levels and body weight data. Mortality outcomes were tracked until December 31, 2019, linking NHANES data with the National Death Index. Statistical analyses included Cox proportional hazards models, Kaplan-Meier survival curves, and subgroup analyses. Results: High GNRI was significantly associated with reduced all-cause and cardiovascular mortality, even after adjusting for potential confounders. The relationship between GNRI and all-cause mortality was nonlinear, with the most significant protective effect observed at GNRI values below 130.55. Subgroup analysis revealed that the effect of GNRI on mortality risk was more pronounced in individuals aged 65 or older and non-Hispanic White people. Conclusion: GNRI is a valuable prognostic tool for predicting mortality risk in OA patients. This study highlights the importance of incorporating nutritional assessments into the management of OA, particularly for high-risk populations. Future research should explore the potential benefits of nutritional interventions based on GNRI levels in reducing mortality among OA patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.